Hospital-level variation in genetic testing in children's hospitals' neonatal intensive care units from 2016 to 2021.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
03 2023
Historique:
received: 27 09 2022
revised: 07 12 2022
accepted: 08 12 2022
pmc-release: 01 03 2024
pubmed: 16 12 2022
medline: 9 3 2023
entrez: 15 12 2022
Statut: ppublish

Résumé

This study aimed to examine variation in genetic testing between neonatal intensive care units (NICUs) across hospitals over time. We performed a multicenter large-scale retrospective cohort study using NICU discharge data from the Pediatric Hospital Information System database between 2016 and 2021. We analyzed the variation in the percentage of NICU patients who had any genetic testing across hospitals and over time. We used a multivariable multilevel logistic regression model to investigate the potential association between patient characteristics and genetic testing. The final analysis included 207,228 neonates from 38 hospitals. Overall, 13% of patients had at least 1 genetic test sent, although this varied from 4% to 50% across hospitals. Over the study period, the proportion of patients tested increased, with the increase disproportionately borne by hospitals already testing high proportions of patients. On average, patients who received genetic testing had higher illness severity. Controlling for severity, however, only minimally reduced the degree of hospital-level variation in genetic testing. The percentage of NICU patients who undergo genetic testing varies among hospitals and increasingly so over time. Variation is largely unexplained by differences in severity between hospitals. The degree of variation suggests that clearer guidelines for NICU genetic testing are warranted.

Identifiants

pubmed: 36521640
pii: S1098-3600(22)01062-0
doi: 10.1016/j.gim.2022.12.004
pmc: PMC9991964
mid: NIHMS1857405
pii:
doi:

Types de publication

Multicenter Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

100357

Subventions

Organisme : NHGRI NIH HHS
ID : T32 HG009496
Pays : United States
Organisme : NICHD NIH HHS
ID : K23 HD102589
Pays : United States

Informations de copyright

Copyright © 2022 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare no conflicts of interest.

Références

Genet Med. 2018 Nov;20(11):1468-1471
pubmed: 29565416
Genet Med. 2018 Nov;20(11):1455-1461
pubmed: 29493583
J Perinatol. 2019 Dec;39(12):1611-1619
pubmed: 31395954
Ann Intern Med. 2003 Feb 18;138(4):288-98
pubmed: 12585826
J Pediatr. 2019 Jun;209:44-51.e2
pubmed: 30955790
JAMA Pediatr. 2021 Dec 1;175(12):1218-1226
pubmed: 34570182
J Perinatol. 2022 Feb;42(2):260-261
pubmed: 34848850
Genet Med. 2019 Aug;21(8):1781-1789
pubmed: 30568310
Hum Genet. 2022 May;141(5):1027-1034
pubmed: 35348890
Health Aff (Millwood). 2018 May;37(5):710-716
pubmed: 29733704
J Pediatr. 2019 Oct;213:211-217.e4
pubmed: 31255390
Int J Neonatal Screen. 2022 Mar 21;8(1):
pubmed: 35323201
J Public Health Manag Pract. 2012 Jan-Feb;18(1):74-8
pubmed: 22139314
Am J Med Genet. 1985 Jun;21(2):231-42
pubmed: 4014310
Pediatrics. 2022 Mar 1;149(3):
pubmed: 35169841
Genet Med. 2017 Aug;19(8):890-899
pubmed: 28125086
Genet Med. 2019 Feb;21(2):498-504
pubmed: 29895853
BMC Pediatr. 2014 Aug 08;14:199
pubmed: 25102958
PLoS One. 2013;8(2):e54900
pubmed: 23418432

Auteurs

Katharine Press Callahan (KP)

Division of Neonatology, Children's Hospital of Philadelphia Philadelphia, PA; Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. Electronic address: callahankp@chop.edu.

Joshua Radack (J)

Division of Neonatology, Children's Hospital of Philadelphia Philadelphia, PA.

Monica H Wojcik (MH)

Divisions of Newborn Medicine and Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Sabrina Malone Jenkins (SM)

Division of Neonatology, Department of Pediatrics, School of Medicine, Health University of Utah, Salt Lake City, UT.

Russell T Nye (RT)

Division of Neonatology, Children's Hospital of Philadelphia Philadelphia, PA.

Cara Skraban (C)

Division of Neonatology, Children's Hospital of Philadelphia Philadelphia, PA.

Katherine Taylor Wild (KT)

Division of Neonatology, Children's Hospital of Philadelphia Philadelphia, PA.

Chris Feudtner (C)

Division of Neonatology, Children's Hospital of Philadelphia Philadelphia, PA; Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH